presented the IMPRESS study, the first prospective multicenter trial comparing Impella CP (n=24) with IABP (n=24).[ 47 ] This study, again, showed no significant difference in mortality rate (50% versus 46%; p=0.92); differences in bleeding complications also failed to reach statistical significance.
← all excerpts
Cardiogenic Shock Management and Research: Past, Present, and Future Outlook.
1
—
—